Anthem Inc (NYSE:ANTM) has been given an average recommendation of “Buy” by the seventeen brokerages that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $317.46.
A number of analysts recently weighed in on ANTM shares. Deutsche Bank initiated coverage on shares of Anthem in a report on Thursday, September 12th. They issued a “buy” rating on the stock. Credit Suisse Group reduced their target price on shares of Anthem from $345.00 to $340.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Zacks Investment Research cut shares of Anthem from a “buy” rating to a “hold” rating and set a $289.00 target price for the company. in a research report on Monday, August 19th. Morgan Stanley dropped their price target on shares of Anthem from $371.00 to $356.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. Finally, Bank of America cut Anthem from a “buy” rating to a “neutral” rating in a report on Friday.
In other news, EVP Peter D. Haytaian sold 9,586 shares of Anthem stock in a transaction on Monday, October 28th. The stock was sold at an average price of $269.57, for a total transaction of $2,584,098.02. Following the transaction, the executive vice president now directly owns 42,488 shares in the company, valued at approximately $11,453,490.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Peter D. Haytaian sold 12,095 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $300.00, for a total value of $3,628,500.00. Following the completion of the sale, the executive vice president now directly owns 41,377 shares in the company, valued at approximately $12,413,100. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,497 shares of company stock valued at $6,446,790. Company insiders own 0.17% of the company’s stock.
NYSE:ANTM traded down $1.03 during midday trading on Monday, reaching $285.27. 1,618,526 shares of the company traded hands, compared to its average volume of 1,676,488. The firm has a market capitalization of $72.33 billion, a price-to-earnings ratio of 17.95, a price-to-earnings-growth ratio of 1.06 and a beta of 0.76. The company has a fifty day moving average price of $278.35 and a 200 day moving average price of $274.15. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.70 and a quick ratio of 1.70. Anthem has a twelve month low of $227.16 and a twelve month high of $317.99.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, October 23rd. The company reported $4.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.82 by $0.05. The firm had revenue of $26.44 billion for the quarter, compared to analyst estimates of $25.88 billion. Anthem had a return on equity of 15.59% and a net margin of 4.29%. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same period last year, the company earned $3.81 earnings per share. On average, equities research analysts forecast that Anthem will post 19.43 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, December 5th will be given a dividend of $0.80 per share. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.12%. Anthem’s dividend payout ratio (DPR) is 20.14%.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Recommended Story: How can investors invest in the S&P/TSX Index?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.